ArticleJournal for immunotherapy of cancer2021

Co-delivery of novel bispecific and trispecific engagers by an amplicon vector augments the therapeutic effect of an HSV-based oncolytic virotherapy.

Divya Ravirala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.